Search Within

Craig Moskowitz

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (50)
  2. Hematologic Malignancies, Division of (50)
  3. Molecular Imaging and Therapy Service (50)
  4. Radiology, Department of (50)
  5. Center for Hematologic Malignancies (47)
  6. Lymphoma (46)

More Groups

People
  1. Heiko Schoder (43)
  2. Andrew Zelenetz (37)
  3. David Straus (33)
  4. Paul Hamlin (27)
  5. Matthew Matasar (25)
  6. Alison Moskowitz (23)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Blood (20)
  2. Journal of Clinical Oncology (11)
  3. Hematological Oncology (4)
  4. Haematologica (3)
  5. Lancet Oncology (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. American Society of Clinical Oncology (11)
  3. Wiley Blackwell (4)
  4. Elsevier Inc. (3)
  5. Ferrata Storti Foundation (3)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of a phase II study of sequential R-CHOP and yttrium-90 ibritumomab tiuxetan (RIT) for elderly high risk patients with untreated diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Hamlin, P. A. Jr; Rodriguez, M. A.; Noy, A.; Portlock, C. S.; Straus, D.; McLaughlin, P.; Pro, B.; Fayad, L.; Hagemeister, F.; Wegner, B.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma? - Reply
    Journal Article

    Moskowitz, C. H.; Zelenetz, A. D.; Schoder, H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Zelenetz, A.; Schoder, H.
    Journal of the National Comprehensive Cancer Network (2010)

    Fulltext@MSK | Save
  • Reply to A. Hüttmann et al
    Journal Article

    Moskowitz, C. H.; Zelenetz, A. D.; Schoder, H.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma
    Journal Article

    Moskowitz, C. H.; Schoder, H.; Teruya-Feldstein, J.; Sima, C.; Iasonos, A.; Portlock, C. S.; Straus, D.; Noy, A.; Palomba, M. L.; O'Connor, O. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The prognostic value of residual FDG-avidity prior to allogeneic stem cell transplantation for lymphoma
    Meeting Abstract

    Sauter, C. S.; Barker, J. N.; Zelenetz, A. D.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
    Blood (2009)

    Fulltext@MSK | Save
  • PET imaging for response assessment in lymphoma: Potential and limitations
    Journal Article

    Schoder, H.; Moskowitz, C.
    Radiologic Clinics of North America (2008)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Initial treatment of mantle cell lymphoma with sequential radioimmunotherapy with Tositumomab/Iodine I131 I-Tositumomab followed by CHOP chemotherapy results in a high complete remission rate
    Meeting Abstract

    Zelenetz, A. D.; Donnelly, G.; Halaas, J.; Sgouros, G.; Humm, J.; Popplewell, L.; Reyes, S.; Maignan, K.; Campbell, C.; Moskowitz, C. H.; more...
    Blood (2003)

    Fulltext@MSK | Save